HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment

AIDS Research and Human Retroviruses

Volumn 16, Issue 18, 2000, Pages 1939-1947

  Burgard, M ^a   Izopet, J ^b   Dumon, B ^c   Tamalet, C ^d   Descamps, D ^e   Ruffault, A ^f   Vabret, A ^g   Bargues, G ^h   Mouroux, M ⁱ   Pellegrin, I ^c   Ivanoff, S ^a   Guisthau, O ^f   Calvez, V ⁱ   Seigneurin, J M ^h   Rouzioux, C ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b CHU PURPAN   (France)

^c HÔPITAL PELLEGRIN   (France)

^d TIMONE HOSPITAL   (France)

^e BICHAT HOSPITAL   (France)

^f RENNES UNIVERSITY HOSPITAL   (France)

^g CAEN UNIVERSITY HOSPITAL   (France)

^h GRENOBLE UNIVERSITY HOSPITAL   (France)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; VIRUS DNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; RNA ANALYSIS; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; VIRAL LOAD;

EID: 0034634905     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200750054666     Document Type: Article

References (23)

1. Quantitative image analysis of HIV-1 infection in lymphoid tissue
2. Viral load and immunophenotype of cells obtained from lymph nodes by fine needle aspiration as compared with peripheral blood cells in HIV-infected patients
3. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
4. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
5. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
6. HIV viral load markers in clinical practice
7. HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS
8. Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo
9. Patterns of HIV-1 transcripts in peripheral blood lymphocytes from long-term nonprogressor and typical progressor patients
10. Detection of low HIV-1 RNA levels in plasma
11. PCR-based assay to quantify HIV-1 DNA in peripheral blood mononuclear cells
12. Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of <200 copies/mL
13. Quantification of HIV-1 viral load in lymphoid and blood cells: Assessment during four-drug combination therapy
14. Evaluation of cell-free and cell-associated peripheral blood human immunodeficiency virus type 1 RNA response to antiretroviral therapy
15. HIV-1 replication in patients with undetectable plasma virus receiving HAART
16. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
17. Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy
18. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
19. Dynamics of provirus load and lymphocyte subsets after interleukin 2 treatment in HIV-infected patients
20. Levels of HIV-infected peripheral blood cells remain stable throughout the natural history of HIV-1 infection
21. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
22. Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy
23. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active antiretroviral therapy